This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Health Care Executive, Scholar And Vice Chancellor From UCLA, Dr. A. Eugene Washington, Appointed To Johnson & Johnson Board Of Directors

Stocks in this article: JNJ

NEW BRUNSWICK, N.J., Nov. 9, 2012 /PRNewswire/ -- Dr. A. Eugene Washington, M.D., M.Sc., who holds several prominent health care executive positions affiliated with the University of California, Los Angeles ( UCLA), has been appointed to the Board of Directors of Johnson & Johnson (NYSE: JNJ), the world's most comprehensive and broadly based health care products company. 

Dr. Washington serves as Vice Chancellor of Health Sciences and Dean of the David Geffen School of Medicine at UCLA, as well as Chief Executive Officer of the UCLA Health System. He is also a distinguished professor of Gynecology and Health Policy at UCLA.  Over his career, he has been published extensively and built an international reputation as a clinical investigator and health policy scholar.

"Gene has dedicated his life to improving health care as a practitioner, researcher, teacher, administrator, and policy advisor.  He brings our Board valuable leadership and insight into analyzing health care policy, assessing medical technologies, and sharing forward-looking perspectives on the role we can play in addressing the world's health care challenges," said Bill Weldon, Chairman of Johnson & Johnson. "He is a welcome addition to the Board, and we look forward to working with him."

Dr. Washington joined UCLA in 2010 and before that he had a long and distinguished career at the University of California San Francisco (UCSF), where he served as executive vice chancellor, provost and professor of gynecology, epidemiology and health policy.  While at UCSF, he also co-founded and served as director of the university's Medical Effectiveness Research Center for Diverse Populations, and also co-founded and served as the first director of the UCSF-Stanford Evidence-based Practice Center. 

Dr. Washington currently serves as Chair of the Board of Governors of the Patient-Centered Outcomes Research Institute, a national research organization authorized by the 2010 Patient Protection and Affordable Care Act.  He is also a member of the Board of Directors of the California Wellness Foundation.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs